Inocras and Broad Institute Unveil Largest Cancer Whole-Genome Analysis
Event summary
- Inocras and Broad Institute analyzed over 8,000 cancer whole-genomes from TCGA across more than 30 cancer types.
- The collaboration identified over 250 million harmonized variant calls, including >1 million somatic structural variants.
- Key insights include new driver mutations, genomic signatures of chromosomal instability, and pathogenic germline variants in ~10% of cases.
- Findings will be presented at the AACR Annual Meeting 2026 on April 20th.
The big picture
This collaboration marks a shift from whole-exome sequencing to comprehensive whole-genome analysis, unlocking previously unexplored regions of the genome. The partnership between Inocras and Broad Institute sets a new standard for large-scale cancer genomics research, potentially transforming how AI models are trained for precision oncology. The findings could lead to more targeted therapies and improved diagnostic capabilities in the future.
What we're watching
- Data Standardization
- How the joint commitment to variant call quality will impact future cancer genomics research.
- AI Model Training
- The pace at which this dataset will be adopted for building AI models in precision oncology.
- Clinical Translation
- Whether these insights can accelerate the development of new cancer therapies and diagnostics.
Related topics